About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maintenance Approaches
By
Nina Shah
5 Videos
August 29, 2017
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
14:16
2nd SOHO Italian Conference
2020 SOHO Update on MM: What Is the Role of Transplant and MRD? How Do Tri…
Feat.
K. Anderson
05:11
UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts
ASH Updates on R/R MM: How to Choose Amongst Available Regimens at 1st Rel…
Feat.
B. Derman
05:09
Association of Community Cancer Centers (ACCC)
72 y/o Woman With IgG Lambda High-Risk Multiple Myeloma (del17p): Disease …
Feat.
K. Maples
18:43
7th Eurasian Hematology Oncology Summit
2020 Updates on CAR-T in R/R MM: What Is the Incidence of AEs With bb2121?…
Feat.
E. Terpos
21:25
UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts
ASH Updates on Frontline MM: What Is the Optimal Induction Regimen? Is It …
Feat.
B. Derman
30:19
SOHO Italy 1st School of Multiple Myeloma
Present & Near Future of R/R MM: Post-Bortezomib, Post-Lenalidomide, Selin…
Feat.
C. Cerchione
09:20
UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review
Curative Strategy for High-Risk Smoldering Myeloma, Consolidation Therapy …
Feat.
A. Rosko
23:44
UAB Hematology Review 2021
Updates on R/R MM: Is PFS Improved With KdD vs. Kd, IKd vs. Kd, Isa-Pd vs.…
Feat.
K. Godby
10:37
Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
State of the Art in the Management of Multiple Myeloma: Smoldering MM, Ind…
Feat.
K. Shain
17:59
Parameswaran Hari
Delivering the Best Initial Treatment for Myeloma: Induction Therapy and R…
12:53
2nd SOHO Italian Conference
Genetic Profiling in MM: Can Genomics Help With High-Risk Disease? How Can…
Feat.
N. Bolli
14:15
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
MRD in Multiple Myeloma Isn't Ready for Prime Time: More Patients Can Achi…
Feat.
T. Martin
16:22
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on Newly Diagnosed MM: Can VMP Combination Improve PFS/O…
Feat.
P. Voorhees
26:18
Morie Gertz
Treatment of Relapsed Myeloma: Overview of Approved Drugs & Optimal Sequen…
08:15
2018 Pan Pacific Lymphoma Conference
Evolution of Myeloma Induction Regimens
Feat.
S. Holstein
25:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases
MM - Overview of Trials Presented at ASH 2018
Feat.
A. Abdallah
14:57
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on HDT in Frontline MM: Is Lenalidomide, Bortezomib, …
Feat.
A. Nooka
13:27
Shaji Kumar
Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma
09:00
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among the My…
Feat.
J. Berdeja
12:16
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Discrepancy Between Real World vs. Clinical Trial Data in Relapsed/Refract…
Feat.
M. Dimopoulos